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PURPOSE. To characterize retinal microglia activation and macrophage recruitment in
experimental branch retinal vein occlusion (BRVO).
METHODS. Experimental BRVO was induced in Balb/c mice and histologic changes were
studied. Tissue hypoxia was visualized using pimonidazole hydrochloride. Monocyte-derived
retinal cells were quantified using histology and flow cytometry. To investigate the dynamics
of invading blood-borne macrophages, chimera mice were generated using bone marrow
grafts from Cx3cr1(gfp/gfp) mice to rescue lethally irradiated wild-type BALB/c mice.
Longitudinal in vivo imaging was performed to monitor cell invasion. The levels of
proinflammatory cytokines in the retina were quantified by quantitative real-time PCR.
RESULTS. Histology showed disruption of tissue architecture and temporary swelling with
marked hypoxia coinciding with increased VEGF-A and hypoxia inducible factor-1a (HIF-1a)
expression and elevation of proinflammatory cytokines within 3 days after experimental
BRVO, followed by thinning of the inner retinal layers at later time points. Proinflammatory
cytokine levels were elevated. Activation of resident retinal microglia and recruitment of
circulating macrophages in areas of hypoxic retina were evident early after the insult and
peaked at day 7, remaining elevated for up to 28 days. Flow cytometry showed upregulation
of CD68 and major histocompatibility complex class-II (MHC-II) expression at day 3,
culminating at day 7.
CONCLUSIONS. Experimental BRVO causes hypoxia and breakdown of the inner blood–retina
barrier, followed by activation of microglia and invasion of macrophages from the systemic
circulation. Consequently, treatments targeting microglia activation or macrophage recruit-
ment might potentially mitigate the sequelae and attenuate degenerative changes induced by
retinal vein occlusion.
Keywords: retinal vein occlusion, macular edema, optical coherence tomography, laser,
photocoagulation, mouse model
Retinal vein occlusion (RVO) is the most common vasculareye disease after diabetic retinopathy, and causes vision loss
due to macular edema, ischemia, and retinal atrophy.1 Macular
edema is the main cause of visual impairment in patients with
RVO. Besides the established role of vascular endothelial
growth factor (VEGF) in the formation of macular edema,
inflammation seems to play a major role in pathogenesis and
chronification.2,3
Retinal vein occlusion causes tissue ischemia, and triggers
an inflammatory cascade that leads to breakdown of the inner
blood–retina barrier,4 which involves adhesion molecules and
a plethora of inflammatory mediators. Elevated vitreous5–7 and
aqueous humor8 levels of presumably involved interleukins
(IL-1b, IL-2, IL-5, IL-6, IL-8, IL-9, IL-10, IL-12, IL-13), chemo-
kines (CCL11, CXCL10, CCL2, CCL4), granulocyte-colony
stimulating factor (G-CSF), interferon-c (IFN-c), tumor necrosis
factor (TNF), and VEGF have been identified in patients with
RVO. Importantly, vitreous levels of mediators such as VEGF
and IL-6 correlated independently with vascular permeability
and the severity of macular edema.9 Resident microglia are
important contributors to inflammation after injury. However,
invading macrophages presumably also help clear debris and
restore tissue integrity.10 Yet overactivation might be detri-
mental.11
Macrophages are a major source of many cytokines, such as
TNF, IL-1, IL-6, IL-8, and IL-12, and central in the regulation of
inflammatory processes.12 As the inflammatory responses may
be influenced at different stages of RVO by therapeutic agents
such as intravitreal steroids13,14 or anti-VEGF agents,15–17 a
better understanding of the cascade of inflammation following
RVO may help guide treatment decisions.
While a wide body of knowledge exists on the role of
macrophages in disease of the outer retina18,19 and experimen-
tal data are available,20 little is known about the dynamics of
macrophages during RVO, a chronic disease of the inner retina
characterized by hypoxia. We and others have previously
described a mouse model of experimental branch retinal vein
occlusion (BRVO).21,22 Here, we aimed at gaining a better
understanding of the contribution of macrophages on the
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course of RVO using histology and fluorescence-activated cell
sorting (FACS) of the retina.
MATERIALS AND METHODS
Animals
This study was approved by the local Animal Ethics Committee
(Veterina¨rdienst des Kantons Bern: BE 38/13) and conformed
to the ARVO Statement for the Use of Animals in Ophthalmic
and Vision Research. BALB/c AnNCrl mice (5–6 weeks old;
Charles River Laboratories, Sulzfeld, Germany) and locally bred
Cx3cr1(gfp/gfp) mice on a Balb/c background were used for this
study. Animals were housed in groups of two to five under
temperature- and humidity-controlled conditions in individual-
ly ventilated cages with a 12-hour light/12-hour dark cycle.
Mice were anesthetized by intraperitoneal injection of 1 mg/kg
medetomidine (Dormitor 1 mg/mL; Provet AG, Lyssach,
Switzerland) and 80 mg/kg ketamine (Ketalar 50 mg/mL;
Parke-Davis, Zurich, Switzerland) for laser procedures. Atipa-
mezol (Antisedan 5 mg/mL; Provet AG) was used to antagonize
medetomidine at the end of the intervention. Pupils were
dilated with tropicamide 0,5%/phenylephrine 2.5% eye drops
(Hospital Pharmacy, Inselspital, Bern, Switzerland). At the end
of the experiment, mice were euthanized by carbon dioxide
inhalation or by terminal anesthesia with pentobarbital (200
mg/kg body weight given intraperitoneally).
Overall, 245 eyes of 126 mice of either sex were included in
this study. A total of 142 eyes were subjected to laser-induced
BRVO, and 88 eyes were used as lasered controls (control). The
remaining 22 eyes were from na¨ıve animals. The BRVO eyes
were analyzed as follows: 20 eyes for histology, immunohisto-
chemistry, and in situ hybridization; 16 eyes for retinal whole
mounts; 16 chimera eyes for fundus autofluorescence imaging
(FAF); 6 eyes for the hypoxia marker staining; 60 eyes for FACS
analysis; and 24 eyes for quantitative real-time polymerase
chain reaction analysis (qRT-PCR). The controls (88 eyes) were
evaluated as follows: 12 eyes for histology, immunohistochem-
istry, and in situ hybridization; 8 eyes for retinal whole mounts;
16 chimera eyes for FAF; 4 eyes for the hypoxia marker
staining; 32 eyes for FACS analysis; and 16 eyes for qRT-PCR.
The remaining 22 eyes were from na¨ıve animals and were
analyzed as follows: 2 eyes for retinal whole mounts, 12 eyes as
na¨ıve controls for FACS analysis, and 8 eyes for qRT-PCR. In
total, seven eyes had to be excluded from the final analysis due
to vitreous hemorrhages.
Laser-Induced Vein Occlusion
Branch retinal vein occlusion was induced by 532-nm laser
photocoagulation (Visulas 532s; Carl Zeiss Meditec AG,
Oberkochen, Germany) with a slit-lamp adapter (Iridex
Corporation, Mountain View, CA, USA) mounted on a slit-lamp
(BM900; Haag-Streit AG, Koeniz, Switzerland) as described
elsewhere.21 A small 2-mm fundus laser lens for mice (Ocular
Instruments, Inc., Bellevue, WA, USA) was used to visualize the
fundus and blood vessels during the laser application. Only one
vein was targeted, and occlusion was considered complete
when stasis of the blood flow distal from the laser burn was
seen during direct fundus observation. In control mice, retinal
laser burns of the same intensity (160 mW, 800 ms) were
performed at comparable distance from the optic nerve but
sparing retinal blood vessels.
Generation of Bone Marrow Chimeras
In total, eight recipient Balb/c AnNCrl mice were lethally
irradiated with two doses of 6.0 Gy given 14 hours apart
without shielding of the eyes. Three donor Cx3cr1(gfp/gfp) mice
were euthanized, and their femurs and tibias were collected.
The bone marrow was removed, and single-cell suspensions
were generated in CSM buffer (2% fetal bovine serum [FBS], 1%
penicillin-streptomycin, 0.01 M HEPES in Hanks’ balanced salt
solution). The cells were filtered through a 70-lm mesh filter
followed by centrifugation at 18g for 5 minutes at 48C. Pelleted
cells were resuspended in Dulbecco’s modified Eagle’s medium
(DMEM) medium (Thermo Fisher Scientific, Waltham, MA,
USA) containing 2% FBS, and live cells were counted using
trypan blue. Recipient irradiated mice received a single
intravenous injection of 1 to 2 3 106 bone marrow cells
within a maximum of 3 hours after the second dose of
irradiation. Bone marrow chimera mice received antibiotics
(0.8 mg/mL sulfamethoxazol and 0.16 mg/mL trimethoprim)
provided in the drinking water for 2 weeks after the
transplantation. One week after bone marrow transplantation,
experimental BRVO was induced in chimera mice.
Fundus Autofluorescence Imaging
The presence and distribution of green fluorescent protein
(GFP)-positive microglia/macrophages in the retina were
longitudinally monitored for several weeks after experimental
BRVO with blue light (488 nm) FAF. Fundus autofluorescence
images were acquired at high resolution of 15363 1636 pixels
using a noncontact ultra-widefield 1028 lens (Heidelberg
Engineering GmbH, Heidelberg, Germany).
Hypoxia Marker
Pimonidazole hydrochloride (Hypoxyprobe-1; Hypoxyprobe,
Inc., Burlington, MA, USA) was intraperitoneally injected at a
dosage of 60 mg/kg body weight in selected mice 90 minutes
prior to killing the animals at day 1 and 4 after experimental
BRVO. The harvested tissue was fixed and processed for
paraffin embedding as detailed below for immunohistochem-
istry.
Histology
Retinal sections were stained with standard hematoxylin–eosin
at different time points after BRVO. Briefly, the sections were
deparaffinized, rehydrated, and consecutively stained with
hematoxylin and eosin following standard protocols. The
sections were then dehydrated and mounted with Eukitt (O.
Kindler GmbH & Co, Freiburg, Germany).
Immunohistochemistry Studies
At selected time points after induction of BRVO, eyes from
euthanized mice were removed and fixed in 4% paraformalde-
hyde (pH 7.4) for 24 hours. Before removal from the animal,
the orientation of the eyes was marked by placing a suture at
the limbus and ensuring correct orientation of specimens
during embedding, since BRVO was systematically induced in
the superonasal quadrant. Eyes underwent routine paraffin
processing, and tissue sections of 5-lm thickness were cut
with a microtome (Leica Biosystems, Muttenz, Switzerland)
and collected on slides. Tissue sections were deparaffinized
and rehydrated before antigen retrieval with Tris–EDTA buffer
(pH 9.0), as previously described in more detail elsewhere.23 A
rabbit polyclonal antibody against ionized calcium-binding
adapter molecule 1 (anti-Iba1 rabbit polyclonal antibody, Wako
Cat. No. 019-19741; Wako Pure Chemical Industries Ltd.,
Osaka, Japan) was applied overnight as the primary antibody to
mark microglia. Visualization was achieved by incubation with
a secondary goat anti-rabbit IgG (HþL), Alexa Fluor 594
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conjugate (1:1000, A27016; Thermo Fisher Scientific. To stain
Mu¨ller cells, an anticellular retinaldehyde-binding protein
rabbit antibody (sc-28193; 1:300; Santa Cruz Biotechnology,
Inc., Dallas, TX, USA) was used as primary antibody, followed
by the secondary goat anti-rabbit antibody (see above). Slides
were mounted with mounting medium containing 4 0,6-
diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlin-
game, CA, USA), coverslipped, and examined under the
microscope.
Immunohistochemical staining of protein adducts of
pimonidazole in hypoxic cells was achieved using a 1:50
dilution of an anti-pimonidazole mouse IgG1 monoclonal
antibody (hybridoma clone 4.3.11.3, Lot 9.7.11; Hypoxyprobe,
Inc.) as the primary antibody overnight, followed by a goat
anti-mouse IgG (HþL) secondary antibody (Alexa Fluor 488
conjugate; 1:250, A11001; Thermo Fisher Scientific).
For preparation of retinal whole mounts, eyes were
removed and fixed in 4% paraformaldehyde solution (pH 7.4)
for 10 minutes. The anterior segment was removed, and the
posterior portion, including the retina, was incubated for
another 50 minutes in 4% paraformaldehyde (pH 7.4). Fixed
retinas were mechanically detached from the choroid and
extensively washed in 0.1% Triton in PBS followed by
incubation in 5% normal goat serum (NGS) in 0.1% Triton in
PBS for 2 hours at room temperature. Isolectin GS-IB4 from
Griffonia simplicifolia (Alexa Fluor 647 conjugate; 1:100 in 5%
NGS in 0.1% Triton in PBS; Thermo Fisher Scientific) and the
rabbit polyclonal antibody against Iba-1 (see above) were used
for double labeling of blood vessels and microglia cells,
respectively. Retinas were incubated with primary antibodies
for 48 hours at 48C. A secondary goat anti-rabbit IgG (HþL)
(Alexa Fluor 594 conjugate; 1:1000, A27016; Thermo Fisher
Scientific) was used for the visualization of Iba-1 staining. In
the chimera mice, a chicken polyclonal antibody against GFP
(1:100, ab13970; Abcam, Cambridge, UK) was used for labeling
of bone marrow–derived macrophages, followed by incubation
with a preabsorbed goat polyclonal antibody to chicken IgY
HþL (FITCH) (1:1000, ab7114; Abcam). Retinas were exten-
sively washed in PBS–0.1% Triton, four radial cuts were made,
and the retinas were flat mounted on a slide with the ganglion
cell layer facing up. Whole mounts were coverslipped and
examined under a confocal microscope.
Microscopy
Retinal sections were examined under an epifluorescence
microscope (Olympus BX60 microscope; Olympus, Tokyo,
Japan). Photoshop (Version 7.0; Adobe Systems, San Jose, CA,
USA) was used to adjust light and contrast. Retinal whole
mounts were imaged using an inverted Zeiss LSM 710
fluorescence confocal microscope (Carl Zeiss Meditec AG). Z-
stacks of 59.6 6 4.6 lm of tissue (mean 6 SEM) with 1-lm
interval were obtained and finalized with the Imaris software
(Version 7.1; Bitplane AG, Zurich, Switzerland). All figures
were prepared using CorelDraw (Corel Corporation, Ottawa,
ON, Canada).
Fluorescence-Activated Cell Sorting
Retinas from experimental mice were dissected at different
time points after BRVO induction and processed for FACS
analysis. The two retinas from the same mouse were combined
to one sample. Briefly, the retinas were dissociated in 0.4
Wu¨nsch Liberase TM Grade (Roche, Basel, Switzerland) in
Dulbecco’s phosphate-buffered saline (DPBS) at 378C for 30
minutes. Single-cell suspensions were obtained and stained
with DAPI (Thermo Fisher Scientific) for detection of dead
cells.24 The samples were washed in DPBS and resuspended in
FACS buffer (100 mM EDTA, 20% FBS, 0.5% Na azide, in DPBS)
for antibody staining; DNase I (0.01%, (Roche) was present in
all solutions. Macrophages were identified using fluorescent-
labeled antibodies against CD45 (30-F11, No. 103116, 1:100),
CD11b (M1/70, No. 101212, 1:100), MHC-II (major histocom-
patibility complex class-II, AF6-120.1, No. 116422, 1:100), and
CD68 (FA-11, No. 137010, 1:100) from Biolegend (San Diego,
CA, USA). Samples were incubated for 20 minutes with
antibodies and then analyzed with a LSR II Cytometer System
using the BD FACSDIVA software (BD Biosciences, Allschwil,
Switzerland). Analysis of the FACS data was performed in the
Flowjo Single Cell Analysis Software V10 (TreeStar, Ashland,
OR, USA).
In Situ Hybridization Studies
Customized probes (Cat. No. 312931, Accession No.
NM_001025257.3; Advanced Cell Diagnostics SRL, Vignate,
Italy) to detect mRNA for VEGF-A were used for in situ
hybridization using the RNAscope 2.0 Red FFPE Kit (Cat No.
310036; Advanced Cell Diagnostics SRL) and an automated
platform (Discovery Ultra; Ventana Medical System–Roche,
Tucson, AZ, USA). The probe region covers 3106 bp spanning
nucleotides 124 to 3230. Expression of dihydrodipicolinate
reductase (DapB) mRNA from Bacillus subtilis and ubiquitin C
(UBC) mRNA were used as negative and positive controls,
respectively. Tissues were examined with bright-field micros-
copy at 340 magnification, and the signal was semiquantita-
tively assessed.
Quantitative Real-Time PCR
Total RNA was isolated using the RNeasy Micro Kit (Qiagen,
Hombrechtikon, Switzerland) per the manufacturer’s instruc-
tions. Total RNA concentration was measured with a spectro-
photometer (Nanodrop 1000; Thermo Fisher Scientific), and
cDNA was synthesized from 1 lg total RNA using the iScript
cDNA Synthesis Kit (Bio-Rad, Hercules, CA, USA) according to
the manufacturer’s instructions. The qRT-PCR reaction mix was
prepared to a final volume of 10 lL and included 6 lL 13 iTaq
Universal SYBR Green Supermix (Bio-Rad), 1 lL of each
forward and reverse primer, and 2 lL 100 ng cDNA. The qRT-
PCR was performed using an iQ5 real-time PCR Detection
System (Bio-Rad). The following primer pairs were used:
b-actin: forward 50-GCTGAGAGGGAAATCGTGCGTG-3 0
reverse 50-CAGGGAGGAAGAGGATGCGG-30
VEGF-A: forward 50-CAGGCTGCTGTAACGATGAA-30
reverse 50-TATGTGCTGGCTTTGGTGAG-30
TNF-a: forward 50-TGTTCATCCATTCTCTACCCAGCCC-30
reverse 50-GTCACTGTCCCAGCATCTTGTGTTT-30
IFN-c: forward 50-GCCTCACCGCCTATCACTCC-30
reverse 50-GGGTCGTGCTCTGCCATCTT-30
HIF1-a: forward 50-TCATCAGTTGCCACTTCCCCAC-30
reverse 50-CCGTCATCTGTTAGCACCATCAC-30
Quantitative RT-PCR reactions were carried out in dupli-
cate, and only comparative threshold cycle (Ct) values leading
to a Ct mean with a standard deviation below 0.1 were
considered. To assess the presence of primer–dimers and to
check for potential contamination, a negative control was
included on each plate. Primer efficiencies were checked, and
only primers with efficiencies between 90% and 110% were
used. The DCt method was used to calculate relative gene
expression levels with b-actin as a housekeeping gene for
normalization of gene expression levels. Two retinas from the
same mouse were used as one sample. Results were
standardized relative to levels measured in na¨ıve retinas.
Macrophage Dynamics in Experimental Vein Occlusion IOVS j February 2017 j Vol. 58 j No. 2 j 946
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/936033/ on 02/08/2017
Statistics
GraphPad Prism 5.0 software (GraphPad Software, Inc., San
Diego, CA, USA) was used for the statistical analysis.
Statistically significant differences of the qRT-PCR data were
determined using 2-way ANOVA with Bonferroni correction for
post hoc tests. One-way ANOVA followed by post hoc tests
with Tukey’s correction was used for the analysis of differences
in the FACS data. P values less than 0.05 were considered
statistically significant. All data are expressed as mean 6 SEM.
RESULTS
Histologic Changes
The histologic analysis of hematoxylin–eosin sections (Fig. 1A)
showed disruption of the tissue architecture and transient
swelling of the retina in the area of the laser lesions, sometimes
with formation of retinal folds at early time points. After 7 days,
there was obvious thinning of the inner layers of the retina in
regions distally to the vein occlusion site (Fig. 1A, upper right
images). The morphology in unaffected areas of retina was
unaltered (Fig. 1A, bottom right images). Analysis of retinal
FIGURE 1. Retinal morphology and microglia activation in experimental BRVO. (A) Representative images of hematoxylin–eosin staining in control
(n¼ 3 at each time point) and BRVO-subjected retinas 3, 7, 14, and 28 days after the laser application (n¼ 5 at each time point). Transient retinal
swelling was observed in the area of the laser lesion 3 days after treatment. Formation of retinal folds at the laser site was also commonly found;
however, postmortem artifacts from processing cannot be excluded. At days 7, 14, and 28, the inner retinal layers were thinned in the areas of the
retina affected by vein occlusion (upper right images). In unaffected areas of the retina, the normal morphology was preserved (lower right
images). Scale bars: 500 lm (left microphotographs); 50 lm (right microphotographs). (B) Representative images of Iba-1 immunoreactivity in
control and BRVO-subjected retinas. Increased numbers of Iba-1–positive cells were present globally in BRVO retinas. The highest density was noted
in areas affected by hypoxia (images on the right) and at the laser site (day 7, on the left). Scale bars: 100 lm (left images); 200 lm (right images).
INL, inner nuclear layer; ONL, outer nuclear layer. No changes were seen in the control retinas (laser burn of identical intensity but not involving a
retinal vein) at the different time points. Thus, only representative pictures of control retinas at day 7 are presented in (A, B), respectively.
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FIGURE 2. Macrophage invasion in retinas with experimental BRVO. (A) Retinal whole mounts at different time points after BRVO (n¼ 3 at each
time point) and control retina (n¼ 2 for each time point) stained for Iba-1. The blood vessel endothelium is labeled with isolectin B4. In the BRVO
retinas, Iba-1–positive cells are accumulating at the laser site (yellow boxes, magnified on the right). No changes were observed in control retinas at
the different time points (laser burn of identical intensity away from retinal vein; representative picture of a control retina at day 7 shown; the
yellow arrow indicates the site of the laser burn). Representative retinal whole mount of a chimera mouse 9 weeks after experimental BRVO,
corresponding to 10 weeks after bone marrow transplantation, is depicted in the bottom right image (chimera). GFP-positive circulating
Macrophage Dynamics in Experimental Vein Occlusion IOVS j February 2017 j Vol. 58 j No. 2 j 948
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/936033/ on 02/08/2017
cross sections stained for Iba-1 at various time points after
induction of BRVO showed markedly increased numbers of Iba-
1–positive cells at the site of laser lesion, peaking at day 7 (Fig.
1B). Moreover, there was an increase in the number of Iba-1–
positive cells distal to the sites of vein occlusion. Retinal whole
mounts (Fig. 2A) revealed that, compared to controls, the
density of Iba-1–positive cells was increased not only in areas
of ischemia or direct laser damage, but also in areas of the
retina not directly affected by the experimental intervention.
In the whole mounts of BRVO eyes, Iba-1–positive microglia/
macrophages were primarily detected in the inner and outer
plexiform layers in confocal microscopy. In areas with
significant infiltration of macrophages (optic nerve, laser site),
the morphology was more commonly of the amoeboid type,
suggesting blood-derived macrophages, whereas in other parts
of the retina the cells had a more ramified appearance. Whole
mounts were additionally stained with isolectin B4 to better
illustrate the relationship of Iba-1–staining cells with retinal
blood vessels. Infiltrating macrophages and microglia densely
lined the walls of the blood vessels damaged by the laser burn.
This pattern was also discernible when evaluating macrophage
invasion in chimeras.
Longitudinal In Vivo Analysis Using FAF in Cx3cr1
Bone Marrow Chimera Mice
Fundus autofluorescence imaging at different time points after
BRVO induction (Fig. 2B) revealed invasion of circulating
macrophages into the retina and accumulation around the laser
site, which peaked 7 days after experimental BRVO. At this
early time point, macrophages were clustering around the laser
site with only scattered cells in the periphery. Twenty-eight
days after the insult, invading macrophages were more
homogeneously distributed over the retina but still at higher
density in the supply territory of the occluded retinal vein. At
the end of the experiment, the invading macrophages in whole
mounts were analyzed by confocal microscopy after enhancing
the GFP signal by immunolabeling. In the inner retinal layers,
amoeboid GFP-positive cells were detected, while in deeper
layers, most of the GFP-positive cells had a more ramified
morphology, typical of resting microglia (Supplementary Fig.
SC).
Double Labeling With Hypoxia Marker
Retinal cross sections from selected animals injected with
pimonidazole hydrochloride ante mortem revealed extensive
areas of hypoxia after experimental vein occlusion (Fig. 3). The
morphology suggested that protein adducts of reductively
activated pimonidazole were mainly localized in Mu¨ller cells,
which was confirmed by double labeling sections for cellular
retinaldehyde-binding protein.
Quantification of Macrophage Accumulation With
FACS
At different time points after the laser application, FACS was
performed in na¨ıve and BRVO-subjected retinas (Fig. 4).
CD45þCD11bþ cell populations, most probably representing
primarily macrophages, were elevated 3, 7, and 14 days after
BRVO, and then returned to control levels 28 days post BRVO
(Fig. 4A). For quantification of the activated macrophage
population (Fig. 4B), we examined the number of major
histocompatibility complex class II (MHC-II)- and CD68-
positive cells. The number of CD45þCD11bþCD68þ cells was
significantly elevated at all time points, while the number of
CD45þCD11bþCD68þMHC-IIþ cells was significantly elevated at
all but the last time point (day 28). Macrophage activation
peaked 7 days after BRVO and steadily decreased over time.
In Situ Hybridization of VEGF mRNA in the BRVO
Retinas
In situ hybridization was performed in control and BRVO
retinas 3 and 7 days after the laser application for qualitative
assessment of VEGF mRNA levels in the retina. Levels of VEGF
macrophages have invaded the laser site (upper left corner) and the retina. Scale bars: 500 lm (left images); 200 lm (right images), 500 lm
(chimera). (B) Longitudinal analysis of macrophage invasion in representative Cx3cr1 bone marrow chimera mouse after experimental BRVO.
Accumulation of macrophages at the laser site is evident 7 days after the insult with lightly scattered macrophages in the rest of the retina. At days 14
and 28, macrophage density is clearly increased in the peripheral retina too. The baseline picture was taken immediately after laser application to
the vein in the left superior quadrant. The bright fluorescence in this vein originates from the rose bengal dye trapped in the occluded vessel and
the thrombus (dilated portion close to the optic nerve head), whereas in the other blood vessels the rose bengal has been washed out.
FIGURE 3. Double labeling of BRVO-affected retina with hypoxia
marker. A representative retinal cross section from an animal
euthanized 4 days after experimental BRVO is shown with ischemic
portions toward the right of the images. A hypoxia marker (hypoxy-
probe [green]) is predominantly found in Mu¨ller cells, labeled with
anticellular retinaldehyde-binding protein antibody (CRALBP [red]). A
retinal section of a control animal stained similarly is shown in the
bottom picture. Scale bar: 200 lm. GCL, ganglion cell layer; ONL,
outer nuclear layer.
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mRNA were elevated compared to controls on days 3 and 7
after experimental BRVO. At both time points, VEGF mRNA
was primarily detected in the inner nuclear layer (Fig. 5A).
Later time points were not examined.
PCR of Hypoxia Markers and Inflammatory
Cytokines in the Retina After BRVO
For relative quantification of hypoxia and proinflammatory
cytokines, qRT-PCR was performed (Fig. 5B). Levels of VEGF-A
mRNA were not altered at any of the time points examined. In
contrast, HIF-1a mRNA expression was increased 3 and 7 days
after BRVO (*P < 0.05 and **P < 0.01 compared to control).
Relative quantification of proinflammatory cytokines revealed
elevation of IFN-c mRNA at day 3 (*P < 0.05), while at day 7,
IFN-c levels were not different from control retinas. The mRNA
levels of other proinflammatory cytokines examined (data not
shown) did not show any statistically significant change during
the first week. On days 14 and 28 after BRVO, none of the
markers analyzed were elevated compared to controls.
DISCUSSION
Retinal vein occlusion supposedly has many similarities with an
ischemic stroke, since the neuroretina forms part of the central
nervous system. Inflammatory processes determine the path-
ophysiology after the hypoxic insult in the central nervous
system, and modulation of inflammation can influence the
sequelae of an ischemic event.25
Here, we showed that the presence of activated microglia
and invading macrophages in the retina is pronounced after
experimental RVO. These cells play a central role in the
FIGURE 4. Macrophage dynamics in experimental BRVO–FACS analysis. (A) Representative FACS plots at different time points after the insult
quantifying CD45þCD11bþ cells (top right boxes). The population of CD45þCD11bþ cells is increased in retinas after experimental BRVO. (B)
Quantification of phagocytic macrophage population (CD45þCD11bþCD68þ) and the portion expressing MHC class II molecules
(CD45þCD11bþCD68þMHC-IIþ). Macrophage accumulation peaked 7 days after experimental BRVO (*P < 0.05, **P < 0.01, ***P < 0.001; 1-way
ANOVA with Tukey post hoc test). Na¨ıve (without any laser): n¼ 6; controls (laser burn of identical intensity away from retinal vein): n¼ 4 each
time point; BRVO: n¼ 6 for days 3 and 7, n¼ 9 for days 14 and 28.
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inflammatory processes in the ischemic retina,4 normally
sequestered from the systemic immune system by the blood–
ocular barrier.26 This study confirms that there is a consider-
able influx of activated bone marrow–derived macrophages,
presumably entering mainly through the central retinal artery
and optic nerve. Activation was paralleled by significant MHC-
II expression in the retina.
Some aspects of our results are comparable to the findings
published by Eter et al.20 in a retina laser lesion model, which
primarily disrupts the outer retinal barrier. Similarly, the
macrophages remained in the retina for more than 4 weeks.
However, in our BRVO model the invasion of macrophages,
despite being prompt after the insult, peaked on day 7,
somewhat later than in the laser model mentioned before,
where the maximum influx was noted around day 2 with
ensuing gradual decline. This may reflect a more insidious but
longer-lasting disruption of primarily the inner blood–retina
barrier. We assume that the major trigger for barrier
breakdown in this RVO model is retinal ischemia,4 which we
have shown to be clearly present (Fig. 4), resulting in increased
VEGF expression (Fig. 5).
Interestingly, the cells most affected by hypoxia seem to be
the Mu¨ller cells (Fig. 3), which constitute an important
component of the inner blood–retina barrier.4,27 Increased
levels of VEGF mRNA were detected in the inner nuclear layer,
a localization consistent with Mu¨ller cells, which have been
shown previously to express VEGF after hypoxia.28 Given the
central role of this cell type in maintaining homeostasis,29,30
one can guess the impact of an ischemic insult in the inner
retina on the function of the neuroretina. However, in this
paradigm, blood–retina barrier disruption and dysfunction
seem for the most part not immediate, unlike what is seen in
suprathreshold thermal laser injury.31
In the retina, microglia are the resident immunocompetent
cells, important in triggering inflammatory processes, which
can entail invasion of monocyte-derived cells from the systemic
circulation.26,32 Yet activated retinal microglia and blood-
derived macrophages express a very similar set of antigens.33,34
Therefore, the distinction between resident microglia and
infiltrating macrophages is not trivial. Chimeric mice using
Cx3cr1(gfp/gfp) lines for bone marrow reconstitution after lethal
irradiation have proven very useful for this purpose.33,35,36 It
has been shown that repopulation and microglia turnover are
normally slow, although differences exist between strains and
protocols.35–39 In the investigated model of BRVO here,
invasion of blood-derived macrophages was marked. The main
sites of entry were the juxtapapillary region, consistent with
the normal path of repopulation in nonlasered chimera, but
even more importantly the site of the laser burn and the
induced thrombus, where the microglia/macrophages accu-
mulated around the vessel wall like a scar (Fig. 2). The cell
morphology patterns observed on Iba-1 whole mounts of wild-
type (Fig. 2A) and chimera mice after experimental BRVO
(Supplementary Fig.) suggest that the infiltrating cells migrate
from the inner retina toward the photoreceptor layer, and
while doing so change their morphology from amoeboid to
ramified. This hypothesis is also supported observations made
by Kezic and McManamin.36
Retinal microglia express several surface molecules in-
volved in immune regulation.40 While major histocompatiblil-
ity class I molecules and the complement receptor 3 (CR3) are
always present but further upregulated in disease, MHC-II
FIGURE 5. mRNA levels of hypoxia markers and inflammatory cytokines. (A) In situ hybridization studies for VEGF mRNA. Elevated levels of VEGF
mRNA were detected in the experimental retinas at 3 and 7 days after BRVO. No changes were observed in the control retinas at the different time
points. Thus, only one representative picture of control tissue at day 7 is shown. Controls: n¼3 at each time point; BRVO: n¼5 at each time point.
Scale bars: 50 lm. INL, inner nuclear layer; ONL, outer nuclear layer. (B) Relative quantification of mRNA levels of hypoxia markers and
proinflammatory cytokines at 3 and 7 days after BRVO in quantitative real-time PCR. HIF-1a mRNA expression is increased at 3 and 7 days after
experimental BRVO (*P < 0.05 and **P < 0.01; 2-way ANOVA with post hoc Bonferroni test). The mRNA level of the proinflammatory cytokine IFN-c
was also elevated at day 3 (*P < 0.05; 2-way ANOVA with post hoc Bonferroni test). Dashed lines indicate the reference levels (100%), which
correspond to na¨ıve retinas. Controls, n ¼ 5; BRVO, n ¼ 8.
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antigens are exclusively expressed by activated micoglia.23,28,41
We used multichannel FACS with antibodies directed against
CD45, CD11b, and CD68 to label highly activated microglia/
macrophages. CD68 (macrosialin) is a macrophage-restricted
glycoprotein and an accepted marker for phagocytotic
activity.42 Notably, it is often used to label the M2 debris
clearing state.43 In this study, only a minority of these
microglia/macrophages (<10%) also expressed MHC-II, re-
quired for antigen presentation and T-helper cell interaction.
Presumably, phagocytosis of cellular debris occurs in an effort
to restore tissue homeostasis by clearing necrotic cells, and
consequently to attenuate the detrimental effects of inflamma-
tion and aid in tissue repair after irreversible damage.
The model has some inherent weaknesses, such as
collateral thermal damage, because laser application disrupts
the ocular privilege.44 However, the risk of damage to the
retinal pigment epithelium was limited by choosing albino
mice. Furthermore, unspecific laser controls with laser
application away from retinal blood vessels were used for
comparison. Moreover, eyes were not shielded for lethal
irradiation of recipient chimera mice. Irradiation of the retina
may itself increase the invasion of donor monocyte-derived
cells into the retina.45
In summary, this study characterized microglia and macro-
phage activity in a paradigm that produces predominantly
inner retinal hypoxia and subsequently inner blood–retina
barrier breakdown. In contrast to models with direct thermal
laser damage, the onset of macrophage activity was somewhat
delayed, but fundamentally displayed a similar kinetics profile.
Only a minority of macrophages expressed MHC-II molecules.
Hypoxia markers were predominantly found in Mu¨ller cells,
which have a critical role in maintaining the integrity of the
inner blood–retina barrier. The inflammatory sequelae subse-
quent to RVO seem substantial, and microglia/macrophages
likely play an important role.
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